MABVAX THERAPEUTICS HOLDINGS, INC. — Form D

MABVAX THERAPEUTICS HOLDINGS, INC. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-13. The offering totals $2.8M, of which $2.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Kenneth CohenDirectorSan Diego, CA
Jeffrey EisenbergDirectorFramingham, MA
Philip LivingstonDirectorSan Diego, CA
Paul MaierDirectorEL CAJON, CA
THOMAS VARVARODirectorIRVINE, CA
Gregory HansonExecutive OfficerSan Diego, CA
Paul MaffuidExecutive OfficerSan Diego, CA
Paul ResnickExecutive OfficerLexington, MA
Robert HoffmanDirectorHouston, TX
Paul V MaierDirectorDeer Park, IL
Thomas C VarvaroDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA
Philip O LivingstonDirectorSan Diego, CA
Philip O LivingstonExecutive OfficerSan Diego, CA
Gregory P HansonExecutive OfficerSan Diego, CA
Paul W ResnickExecutive OfficerSan Diego, CA
Jeffrey F EisenbergDirectorSan Diego, CA
Paul W MaffuidExecutive OfficerSan Diego, CA
Gregory HansonDirectorSan Diego, CA
Jeffrey RavetchDirectorSan Diego, CA
Thomas VarranoDirectorSan Diego, CA
Jeffrey V RavetchDirectorSan Diego, CA
J. David HansenDirectorSan Diego, CA
J. David HansenExecutive OfficerSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2018-05-15D$860K$830K
2015-04-09D$15.0M$11.6M
2014-07-10D$5.2M$5.2M
2014-05-22D$4.6M$4.6M

More